Skip to Content

Portable Brain Imaging May Provide a Roadside Pot Test

January 10, 2018

There may still be a better way than the “walk and turn” for cops eager to catch drugged drivers.

The problem: Many states are legalizing marijuana, but the way our bodies process it makes it hard to create objective tests to determine if someone is too high to drive. Previous attempts to create such tests have come to naught.

What’s new:  Stat reports that a brain cap could reveal shifts in brain activity that may be linked to unsafe levels of cannabis use. The device uses a technique called functional near-infrared spectroscopy, which bounces light around the inside of the skull to measure changes in blood flow that may correspond to shifting communication between parts of the brain.

But: Researchers are still trying to ensure that the signals they see are actually a result of drug impairment. And it’s unclear how cops would use the device at the roadside.

Deep Dive


These scientists used CRISPR to put an alligator gene into catfish

The resulting fish appear to be more resistant to disease and could improve commercial production—should they ever be approved.

Next up for CRISPR: Gene editing for the masses?

Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.

CRISPR for high cholesterol: 10 Breakthrough Technologies 2023

New forms of the gene-editing tool could enable treatments for common diseases.

An ALS patient set a record for communicating via a brain implant: 62 words per minute

Brain interfaces could let paralyzed people speak at almost normal speeds.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.